Cosmos Health Inc. (COSM), a healthcare company, on Friday reported that the proprietary products under Sky Life Premium will be sold across 27 countries in the European Union.
The company reported that a total of 96 Sky Life Premium products will be available for purchase via the e-commerce platform Skroutz, accessing key markets in Western, Northern, Central, and Eastern Europe.
The products consist of various pharmaceutical, nutraceutical, food supplements, biocides, and medical devices, licensed in Europe to the subsidiary Cana Laboratories S.A. All products were certified by the European Medicines Agency (EMA).
Chief Executive Officer (CEO), Greg Siokas, was quoted, saying "This initiative further enhances our brand visibility and supports our continued focus on driving revenue growth and expanding our global presence."
COSM closed Thursday at $0.27, up 9.81%. In the pre-market, shares are trading at $0.28, up 3.36%.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.